Advertisement
Research ArticleNeuropharmacology

CEP-26401 (Irdabisant), a Potent and Selective Histamine H3 Receptor Antagonist/Inverse Agonist with Cognition-Enhancing and Wake-Promoting Activities

Rita Raddatz, Robert L. Hudkins, Joanne R. Mathiasen, John A. Gruner, Dorothy G. Flood, Lisa D. Aimone, Siyuan Le, Hervé Schaffhauser, Emir Duzic, Maciej Gasior, Donna Bozyczko-Coyne, Michael J. Marino, Mark A. Ator, Edward R. Bacon, John P. Mallamo and Michael Williams
Journal of Pharmacology and Experimental Therapeutics January 2012, 340 (1) 124-133; DOI: https://doi.org/10.1124/jpet.111.186585
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleNeuropharmacology

H3 Receptor Antagonist CEP-26401

Rita Raddatz, Robert L. Hudkins, Joanne R. Mathiasen, John A. Gruner, Dorothy G. Flood, Lisa D. Aimone, Siyuan Le, Hervé Schaffhauser, Emir Duzic, Maciej Gasior, Donna Bozyczko-Coyne, Michael J. Marino, Mark A. Ator, Edward R. Bacon, John P. Mallamo and Michael Williams
Journal of Pharmacology and Experimental Therapeutics January 1, 2012, 340 (1) 124-133; DOI: https://doi.org/10.1124/jpet.111.186585
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement